Consensus Ventas, Inc. Deutsche Boerse AG

Stocks

VEN

US92276F1003

Specialized REITs

Market Closed - Deutsche Boerse AG 11:32:27 31/08/2026 am IST			After hours 01:30:00 am
78.64 ^EUR	-0.93%		78.49	-0.19%

03:09pm	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
14/08	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT

Evolution of the Average Target: Ventas, Inc.

Evolution of the Target Price: Ventas, Inc.

Changes in Analyst Recommendations: Ventas, Inc.

00289f29d8c7d731a325.s1Z2a9yMBVPHt5TL01PrSaCPxCiMyGMtqa2GjhNI2Vc.4BEDDrLqRxKVhvHm6wPGO9nnsH_-rRMa2fXNo1odowOKAE8GnuRDH67E1Q~f4cb3af5291fcc8bd800b104ffa3d4c8

Analysts' recommendations: Ventas, Inc.

03:09pm	Barclays Adjusts Price Target on Ventas to $102 From $99, Keeps Equalweight Rating	MT
14/08	Ventas Earnings Growth Supported by Strong Senior Housing Trends, RBC Says	MT
14/08	RBC Adjusts Price Target on Ventas to $99 From $98, Maintains Outperform Rating	MT
12/08	Jefferies Adjusts Price Target on Ventas to $102 From $109, Maintains Buy Rating	MT
11/08	BMO Capital Adjusts Price Target on Ventas to $107 From $105, Keeps Outperform Rating	MT
05/08	Argus Research Adjusts Ventas Price Target to $98 From $92	MT
04/08	Citigroup Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
03/08	Evercore ISI Adjusts Price Target on Ventas to $101 From $96, Maintains Outperform Rating	MT
03/08	BMO Capital Adjusts Price Target on Ventas to $105 From $100, Maintains Outperform Rating	MT
30/07	BNP Paribas Adjusts Ventas Price Target to $110 From $93, Maintains Outperform Rating	MT
24/07	Goldman Sachs Adjusts Price Target on Ventas to $114 From $110, Maintains Buy Rating	MT
22/07	Mizuho Adjusts Price Target on Ventas to $104 From $98, Maintains Outperform Rating	MT
15/07	Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating	MT
10/07	Scotiabank Adjusts Price Target on Ventas to $93 From $88	MT
01/07	Evercore ISI Adjusts Ventas Price Target to $96 From $95, Maintains Outperform Rating	MT
18/06	Scotiabank Adjusts Price Target on Ventas to $88 From $95, Maintains Sector Perform Rating	MT
16/06	Deutsche Bank Lifts Price Target on Ventas to $100 From $95, Keeps Buy Rating	MT
01/06	Wells Fargo Adjusts Price Target on Ventas to $96 From $93, Maintains Overweight Rating	MT
26/05	BofA Adjusts Price Target on Ventas to $110 From $102	MT
22/05	Baird Adjusts Price Target on Ventas to $98 From $97, Maintains Outperform Rating	MT
22/05	Mizuho Adjusts Price Target on Ventas to $98 From $94, Maintains Outperform Rating	MT
21/05	Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating	MT
19/05	Goldman Sachs Adjusts Price Target on Ventas to $110 From $100, Maintains Buy Rating	MT
13/05	Jefferies Adjusts Price Target on Ventas to $100 From $97, Maintains Buy Rating	MT
11/05	JPMorgan Adjusts Price Target on Ventas to $94 From $93	MT

More recommendations

Healthcare REITs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
VENTAS, INC.	-	-	-	-
WELLTOWER INC.				+7.84%
VENTAS, INC.				+9.42%
HEALTHPEAK PROPERTIES, INC.				+9.73%
OMEGA HEALTHCARE INVESTORS, INC.				+13.07%
AMERICAN HEALTHCARE REIT, INC.				+14.65%
CARETRUST REIT, INC.				+16.28%
AEDIFICA				+21.73%
HEALTHCARE REALTY TRUST INCORPORATED				+13.66%
SABRA HEALTH CARE REIT, INC.				+9.86%
Average				+12.91%
Weighted average by Cap.				+9.51%